Management of parotid gland tumors in infants and children.
Seventy-four pediatric patients with parotid gland tumors were seen during a 52-year period. Seventy percent of the lesions were benign and 30% were malignant. When the primary treatment is either subtotal or total parotidectomy, the recurrence rate was 2.3%.  The facial nerve should be dissected free of parotid parenchyma and preserved, except if the lesion was malignant--a situation in which the nerve might have to be sacrificed totally or in part to ensure adequate tumor removal. No patient died of a benign or malignant lesion in this series, and the morbidity after surgical removal of primary tumors of the parotid gland in children and infants was low.
D000293:Adolescent; D000367:Age Factors; D002277:Carcinoma / Q000601:surgery*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006391:Hemangioma / Q000601:surgery*; D006801:Humans; D007223:Infant; D008068:Lipomatosis / Q000601:surgery*; D008202:Lymphangioma / Q000601:surgery*; D008297:Male; D008910:Minnesota; D009362:Neoplasm Metastasis; D009373:Neoplasms, Germ Cell and Embryonal / Q000601:surgery*; D009442:Neurilemmoma / Q000601:surgery*; D009455:Neurofibroma / Q000601:surgery*; D010306:Parotid Gland / Q000601:surgery; D010307:Parotid Neoplasms / Q000453:epidemiology / Q000401:mortality / Q000601:surgery*; D012008:Recurrence